ARTICLE | Clinical News
AllerT: Completed clinical trial enrollment
April 28, 2014 7:00 AM UTC
Anergis completed enrollment of 196 patients with moderate to severe birch pollen allergy in a double-blind, placebo-controlled, European observational study evaluating subcutaneous AllerT for up to 3...